Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:EQURNASDAQ:HSDTOTCMKTS:PBIOOTCMKTS:VRSEF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEQURADB International Group$0.00$0.00$0.00▼$0.05N/AN/AN/AN/AHSDTHelius Medical Technologies$0.21-37.9%$2.93$0.20▼$24.00$180K1.121.65 million shs13.77 million shsPBIOPressure BioSciences$0.00+26.7%$0.00$0.00▼$0.21$60K-0.710,385 shs1,839 shsVRSEFVerisante Technology$0.00$0.00$0.00▼$0.01$100K18.29N/AN/A7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEQURADB International Group0.00%0.00%0.00%0.00%0.00%HSDTHelius Medical Technologies-37.92%-36.06%-94.12%-96.65%-98.63%PBIOPressure BioSciences+26.67%-24.00%-54.76%-85.93%-98.50%VRSEFVerisante Technology0.00%0.00%+4.76%-56.00%-4.35%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEQURADB International GroupN/AN/AN/AN/AN/AN/AN/AN/AHSDTHelius Medical Technologies0.6151 of 5 stars0.02.00.00.03.10.80.6PBIOPressure BioSciences0.1061 of 5 stars0.03.00.00.00.00.80.0VRSEFVerisante TechnologyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEQURADB International Group 0.00N/AN/AN/AHSDTHelius Medical Technologies 2.00HoldN/AN/APBIOPressure BioSciences 0.00N/AN/AN/AVRSEFVerisante Technology 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEQURADB International GroupN/AN/AN/AN/AN/AN/AHSDTHelius Medical Technologies$520K0.22N/AN/A$4.26 per share0.05PBIOPressure BioSciences$1.98M0.04N/AN/A($1.29) per share0.00VRSEFVerisante TechnologyN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEQURADB International GroupN/AN/A0.00∞N/AN/AN/AN/AN/AHSDTHelius Medical Technologies-$11.74M-$47.53N/A∞N/A-3,010.14%-418.82%-243.54%8/11/2025 (Estimated)PBIOPressure BioSciences-$29.31M-$0.96N/A∞N/AN/AN/AN/AN/AVRSEFVerisante Technology-$80KN/A0.00∞N/AN/AN/A-901.36%N/ALatest VRSEF, HSDT, PBIO, and EQUR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025HSDTHelius Medical Technologies-$0.58-$0.51+$0.07-$0.51N/A$0.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEQURADB International GroupN/AN/AN/AN/AN/AHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/APBIOPressure BioSciencesN/AN/AN/AN/AN/AVRSEFVerisante TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEQURADB International GroupN/AN/AN/AHSDTHelius Medical TechnologiesN/A1.691.13PBIOPressure BioSciencesN/AN/AN/AVRSEFVerisante TechnologyN/A0.530.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEQURADB International GroupN/AHSDTHelius Medical Technologies18.63%PBIOPressure BioSciences0.02%VRSEFVerisante TechnologyN/AInsider OwnershipCompanyInsider OwnershipEQURADB International Group79.63%HSDTHelius Medical Technologies17.90%PBIOPressure BioSciences10.80%VRSEFVerisante TechnologyN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEQURADB International Group1N/AN/ANot OptionableHSDTHelius Medical Technologies30530,000433,000Not OptionablePBIOPressure BioSciences1042.97 million38.33 millionNot OptionableVRSEFVerisante TechnologyN/A43.94 millionN/ANot OptionableVRSEF, HSDT, PBIO, and EQUR HeadlinesRecent News About These CompaniesVER.H:CA AnalysisApril 10, 2025 | seekingalpha.comVerisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AGMarch 31, 2025 | accessnewswire.comAVerisante Technology, Inc. Announces RTO Update:December 18, 2024 | accesswire.comAVerisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AGOctober 31, 2024 | accesswire.comAVerisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AGAugust 13, 2024 | accesswire.comAClosing Bell: Verisante Technology Inc down on Friday (VER-H)August 7, 2024 | theglobeandmail.comClosing Bell: Verisante Technology Inc up on Tuesday (VER-H)July 24, 2024 | theglobeandmail.comVerisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt TransactionMarch 30, 2024 | accesswire.comAVerisante: Q4 Earnings SnapshotMarch 29, 2024 | sfgate.comVerisante Technology, Inc. Announces Shares for Debt AgreementsMarch 14, 2024 | accesswire.comAVerisante Technology, Inc. Announces 2023 AGM ResultsDecember 21, 2023 | finance.yahoo.comVerisante Technology, Inc. Announces Exchange Approval for Shares for Debt TransactionOctober 5, 2023 | finance.yahoo.comVerisante Technology Inc. Announces Shares for Debt AgreementsSeptember 8, 2023 | finance.yahoo.comVerisante: Q2 Earnings SnapshotAugust 15, 2023 | wtop.comWLatest Technology NewsMarch 30, 2023 | prweek.comPVerisante Technology, Inc. Announces Exchange Acceptance for Shares for Debt TransactionsNovember 23, 2022 | finance.yahoo.comVerisante: Q3 Earnings SnapshotNovember 18, 2022 | sfgate.comVerisante Technology, Inc.: Verisante Technology Inc. Announces Proposed Shares for Debt TransactionOctober 22, 2022 | finanznachrichten.deVerisante Technology Inc. Announces Proposed Shares for Debt TransactionOctober 19, 2022 | finance.yahoo.comVerisante Technology Inc. Announces Closing Non-Brokered Private PlacementJuly 13, 2022 | apnews.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeVRSEF, HSDT, PBIO, and EQUR Company DescriptionsADB International Group OTCMKTS:EQUR$0.0002 0.00 (0.00%) As of 10/5/2023E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.Helius Medical Technologies NASDAQ:HSDT$0.21 -0.13 (-37.92%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.21 0.00 (-1.42%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Pressure BioSciences OTCMKTS:PBIO$0.0019 +0.00 (+26.67%) As of 06/27/2025 03:08 PM EasternPressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Verisante Technology OTCMKTS:VRSEF$0.0022 0.00 (0.00%) As of 06/26/2025Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
